Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06313359 · ClinicalTrials.gov registry record
Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.
A clinical trial of Peripheral Neuropathy Due to Chemotherapy, sponsored by Texas Woman's University.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06313359 is a study of Peripheral Neuropathy Due to Chemotherapy that is actively recruiting participants, run by Texas Woman's University. The registered enrollment target is 40 participants, below the 54-participant average among 6 other Peripheral Neuropathy Due to Chemotherapy trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06313359, a study of Peripheral Neuropathy Due to Chemotherapy, is actively recruiting participants, sponsored by Texas Woman's University.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.
Conditions Studied
Study Locations (1)
Texas
- Texas Woman's University - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-03-30 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06313359
The ClinicalTrials.gov registry entry for NCT06313359 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 54-participant average among 6 other Peripheral Neuropathy Due to Chemotherapy trials with a reported enrollment target (26% lower). The listed sponsor is Texas Woman's University, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Neuropathy Due to Chemotherapy appearing as the primary indexed condition, and to 0 interventions.
NCT06313359 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06313359 about?
NCT06313359 is a clinical study titled "Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.". The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or mo...
What is the current status of trial NCT06313359?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-03-30. Estimated completion is 2026-06-30.
What conditions does trial NCT06313359 study?
This clinical trial studies the following conditions: Peripheral Neuropathy Due to Chemotherapy.
Who is sponsoring clinical trial NCT06313359?
This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06313359 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Neuropathy Due to Chemotherapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
RECRUITING · NA
-
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
RECRUITING · NA
-
Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial
RECRUITING · NA
-
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
RECRUITING · Early Phase 1
-
Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.
RECRUITING · NA
-
Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.